ASCL1 and small cell lung carcinoma: In the neuroendocrine group, SCLC‐A tumors are driven by overexpression of Achaete‐scute homolog 1 (ASCL1) while SCLC‐N tumors are driven by Neurogenic Differentiation 1 (NEUROD1) overexpression.